1. Home
  2. NTRA vs EQT Comparison

NTRA vs EQT Comparison

Compare NTRA & EQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.88

Market Cap

29.2B

Sector

Health Care

ML Signal

HOLD

Logo EQT Corporation

EQT

EQT Corporation

HOLD

Current Price

$56.68

Market Cap

34.2B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
EQT
Founded
2003
1925
Country
United States
United States
Employees
N/A
1873
Industry
Medical Specialities
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
29.2B
34.2B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
NTRA
EQT
Price
$197.88
$56.68
Analyst Decision
Strong Buy
Buy
Analyst Count
15
21
Target Price
$259.07
$69.15
AVG Volume (30 Days)
1.4M
6.8M
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
1.12%
EPS Growth
0.65
635.56
EPS
N/A
2.36
Revenue
$210,939,000.00
$8,644,211,000.00
Revenue This Year
$18.08
$20.28
Revenue Next Year
$19.65
N/A
P/E Ratio
N/A
$23.69
Revenue Growth
N/A
63.92
52 Week Low
$131.81
$48.47
52 Week High
$256.36
$68.24

Technical Indicators

Market Signals
Indicator
NTRA
EQT
Relative Strength Index (RSI) 46.96 41.53
Support Level $187.27 $56.26
Resistance Level $204.34 $57.62
Average True Range (ATR) 10.36 1.36
MACD -1.12 -0.13
Stochastic Oscillator 28.02 27.60

Price Performance

Historical Comparison
NTRA
EQT

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About EQT EQT Corporation

EQT is an independent natural gas production company. It focuses its operations in the cores of the Marcellus and Utica shales, located in the Appalachian Basin in the Eastern United States. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has three reportable segments in production, gathering, and its transmission segment, which is now an operated joint venture with Blackstone. All the firm's operating revenue is generated in the US, with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.

Share on Social Networks: